Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 86, Issue 4, Pages 381-384Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.icb.7100165
Keywords
T lymphocyte; human; integrin; costimulation; CD45
Categories
Funding
- NCI NIH HHS [CA09598] Funding Source: Medline
Ask authors/readers for more resources
CD45RA T cells are fully co-activated by natural beta 1 integrin ligands fibronectin (FN) and VCAM-1, as well as monoclonal antibody (mAb) 19H8, which binds a combinatorial epitope of the alpha 4 beta 1 heterodimer. These integrin ligands stimulate CD3-dependent proliferation and the upregulation of early activation markers CD25 and CD69. However, beta 1-specific antibody 33B6, which binds to a similar range of the predominant T-cell integrins as natural ligands FN (alpha 4 beta 1 and alpha 5 beta 1) and VCAM-1 (alpha 4 beta 1), failed to costimulate proliferation in the CD45RA subset, while retaining the ability to costimulate early activation markers CD25 and CD69. After addition of exogenous human interleukin-2 to the culture media, 33B6 costimulation of proliferation is restored. These data provide evidence that a branch of the alpha 4 beta 1 integrin-signaling pathway in CD45RA T cells can be independently regulated and exploited through the use of partial agonist ligands, including mAbs to the integrin heterodimer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available